# Discriminator report

## Scenario echo
The scenario is healthy/baseline human pancreas with no specified age, sex, or focused notes, and `celltype=null` means the embedding should cover the expected pancreas cell landscape: endocrine islet cells, exocrine acinar and ductal epithelium, vascular and lymphatic endothelium, stromal/stellate/mural cells, neural/Schwann cells, and resident or contaminating immune populations.

## Rating: minor
The blueprint is broadly plausible and covers the major human pancreas compartments and canonical endocrine/exocrine subtypes. It still has a few targeted biological design issues that could blur important stromal and rare endocrine distinctions, but it does not need structural rework.

## Findings

### Minor issues
- **mesenchymal_core / mesenchymal gated axes** — The mesenchymal gate is heavily fibroblast/ECM-weighted (`COL1A1`, `COL1A2`, `COL3A1`, `DCN`, `LUM`, `COL6A1`, `COL6A2`, `VIM`). This is good for fibroblast/stellate cells but a weak common gate for pericytes and vascular smooth muscle, which are then resolved only under that collagen-rich gate. In actual pancreas data this could under-score mural cells despite the `pericyte_smooth_muscle` module itself being canonical.
  *Fix:* Broaden the stromal/mural gating design: either add mural markers such as `PDGFRB`, `RGS5`, `CSPG4`, `MCAM`, `NOTCH3`, `ACTA2`, `TAGLN` into a more inclusive mesenchymal/mural core, or make the mural identity a plain/less fibroblast-gated axis while retaining the fibroblast/stellate axis separately.

- **epsilon_cell** — The epsilon-cell module is mostly generic endocrine markers (`CHGA`, `CHGB`, `PCSK1`, `ISL1`) plus `GHRL`. Since epsilon cells are rare and strongly defined by ghrelin biology, this module may behave more like a generic endocrine subscore than a specific epsilon identity, especially when gated by `endocrine_core`.
  *Fix:* Strengthen the module with additional literature-supported human epsilon/ghrelin-cell markers if available, or keep it but reduce generic endocrine overlap so the axis is driven primarily by epsilon-specific signal. If no stronger adult human support is available, explicitly keep the rare-cell axis conservative rather than expanding with speculative markers.

- **stellate_myofibroblast_activation** — The activated stellate/myofibroblast module is biologically recognizable, but its markers (`POSTN`, `SERPINE1`, `TIMP1`, strong fibrillar collagens) lean toward injury/fibrosis or dissociation-activated matrix remodeling. In a baseline healthy-pancreas scenario, it should be treated as a state within stellate/fibroblast biology rather than as an equally primary pancreas cell population.
  *Fix:* Rename/reframe the axis as a fibroblast/stellate matrix-remodeling or activation state, and keep it gated within stromal cells. Do not remove it; just avoid making it look like a separate healthy lineage on par with quiescent stellate/fibroblast or mural cells.

## Out of scope (FYI, not actionable for the Generator)
- Citation verification was not performed; this review only judged biological coverage and marker plausibility.

## Summary for the next round
Focus on tightening stromal biology: make the mesenchymal/mural gate less fibroblast-biased, keep activated stellate biology as a scoped state rather than a separate healthy lineage, and sharpen the rare epsilon-cell signature if the human literature supports stronger markers.
